On April 1, 2024 the Federal Circuit released its opinion in Janssen Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al., affirming the district court’s finding that certain claims were not indefinite and...more
On December 26, 2023, the United States Court of Appeals for the Federal Circuit issued its decision in K-Fee System GMBH v. Nespresso USA, Inc. While nominally a case related to coffee makers, its teachings are highly...more
On May 5, 2022, the Office of Foreign Assets Control of the U.S. Department of the Treasury issued General License No. 31 (“GL31”), which authorizes transactions in connection with the filing and prosecution of patent...more
5/9/2022
/ Australia ,
Canada ,
Economic Sanctions ,
EU ,
General Licenses ,
Member State ,
Military Conflict ,
Office of Foreign Assets Control (OFAC) ,
Patent Infringement ,
Patent Prosecution ,
Patents ,
Russia ,
UK
Seven years after the Member States of the EU signed the Agreement on a Unified Patent Court (“UPCA”), the Unitary Patent (“UP”) and the Unified Patent Court (“UPC”) are likely to commence during the second half of 2022. This...more
4/20/2022
/ Corporate Counsel ,
Enforcement Actions ,
EU ,
European Patent Convention ,
European Patent Office ,
Intellectual Property Protection ,
Member State ,
Opt-Outs ,
Patent Applications ,
Patent Filings ,
Patent Infringement ,
Patent Litigation ,
Patent Prosecution ,
Patents ,
Unified Patent Court ,
Unitary Patent
On May 11, 2021, Alvotech USA and Alvotech hf (jointly, Alvotech) filed a complaint seeking declaratory judgement against AbbVie Inc. and AbbVie Biotechnology Ltd (jointly, AbbVie) in the Eastern District of Virginia. As...more